Microfluidics is an evolving scientific field with numerous analytical applications and commercial potential. It has several applications in the field of medicine, cell biology research and protein crystallization. Thus, microfluidic technology is an important tool to reduce side effects and improve the efficacy of treatments.
North America has the largest share in the global microfluidic device market. In-vitro diagnostics is the largest industry, and clinical and veterinary diagnostics is the largest application of microfluidic device market. In terms of growth, Asia is the fastest growing region, medical devices are the fastest growing industry and point of care testing is the fastest growing application of microfluidic devices.

The global Microfluidic Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Microfluidic Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Microfluidic Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Microfluidic Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Microfluidic Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Roche
Abbott
Fluidigm Corporation
Johnson & Johnson
Siemens Healthcare
Agilent
Bio-Rad Laboratories
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Polymer
Glass
Silicon
Other

Segment by Application
In-vitro Diagnostics (IVD)
Pharmaceuticals and Medical Devices
Other